About Us
The Shoalhaven Medical Association was founded over 50 years ago to organise ongoing medical education for GPs as well as provide a social network for our families. We are an independent, not for profit organisation run by a committee of local doctors.
READ MORE
Schedule
- Bill & Pat Ryan Memorial Session
- Morning Session
- Afternoon Session
- Main Meeting Room
Dom has experienced childhood heart disease from both sides of the fence: as doctor and patient. His memoir ‘MALACHY’ shares the travails of his own son, born with a hypoplastic right heart. Dom reflects on the traumatic nature of treatment for CHD, the challenges facing medical carers, the importance of peer support and the difference it makes to families when we, as doctors, get it right
A/Professor Rachael Cordina is a clinical academic cardiologist. She is Head of the Adult Congenital Heart Disease Team at Royal Prince Alfred Hospital, the NSW referral center and a Consultant Cardiologist at the Aboriginal Health Service in Redfern. She runs outreach clinics across NSW and the Northern Territory. She is also a part-time resident of the Shoalhaven.
Dr Philip Roberts is an interventional cardiologist at the Heart Centre for Children, Westmead Children’s Hospital. He is an expert in congenital heart disease and in other paediatric cardiac issues. Dr Roberts has been involved in new, groundbreaking percutaneous treatments of paediatric valvular heart disease. Known as a self-expanding large diameter transcatheter pulmonary valve replacement, (TPVR) allows doctors to replace the pulmonary heart valve using a vein in the leg to access the heart
- Main Meeting Room
Dr Danson is an interventional cardiologist based in the Illawarra & the Shoalhaven. He trained in Oxford & London in the UK & Sydney before settling in Wollongong in 2017. Originally an academic cardiologist, he was Clinical Lecturer in Cardiology at King’s College Hospital in London. His current interests are in catheter treatments for heart valve conditions and novel risk mitigation steps for high-risk patients in the cath lab including close collaboration with cardiac surgeons. His proudest contribution so far has been to the development of a comprehensive Heart Team including cardiac surgery in the Illawarra
Cardiovascular disease remains the leading cause of morbidity and mortality worldwide, yet our tools for prevention and management are rapidly evolving. This presentation will explore the latest approaches to CVD risk screening, including the arrival of new calculators. It will also highlight strategies for identifying familial hypercholesterolaemia. There will be a discussion on management options and how to think longer than 5 – 10years and also the role CT calcium scores, apob100 and lipoprotein (a). Hopefully this provides some strategies to keep your patients alive and well
- Main Meeting Room
Cardiology has made great advances, but what happens when modern interventions aren’t available or suitable? Medicine often presents the challenge of knowing a treatment exists but access, timing, or risk prevents its use. In those cases, we turn to alternatives — old remedies, creative combinations, or drugs accessed through special schemes. Whether dealing with heart failure, angina, or arrhythmias, this talk will share practical “last-resort” approaches and tricks of the trade that may prove useful.
Technology has always shaped and driven cardiac surgery, from cardiopulmonary bypass, to advances in cardioplegia, the development of mechanical and bioprosthetic valves, or to today’s minimally invasiveness of surgical intervention. As patients continue to grow older and sicker, they will require progressively more complex procedures and will simultaneously demand less invasive treatments of their disease, leading to an increase in the number of combined procedures performed and the number of interventions necessary. Recent advances include use of minimally invasive surgeries, trans catheter interventions and mechanical circulatory support.
A discussion on the challenges and pitfalls in managing hypertension in the difficult minority and advice on how to monitor and improve blood pressure in this cohort. In particular, it will cover blood pressure management in resistant hypertension, CKD, the elderly, and the non-compliant with practical suggestions on how to manage common complications such as hyperkalaemia and drug interactions, using current guidelines where available.
